Chemomab Therapeutics Ltd. (CMMB)
Market Closed
30 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 53
+0.07
+4.7945%
$
8.8M Market Cap
- P/E Ratio
- Div Yield
57,516 Volume
- Eps
$ 1.46
Previous Close 
Want to track CMMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Chemomab Therapeutics Ltd. (CMMB) Statistics
Valuation metrics
Market Cap 8.8M
Enterprise value 2.46M
Trailing P/E (ttm) -1.23
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 1.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 42.2K
Average volume (90 days) 51.51K
Price summary
52-Week low 1.35
52-Week high 4.54
Beta -
50-Day moving average 1.58
200-Day moving average 1.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 26 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.63%
Return on equity -0.68%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.93
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.01
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 10.31%
Book value per share (mrq) 1.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
